National Registry of Diseases (Cancer Notification) Regulations 2009

No. S 353

National Registry of Diseases Act

(Chapter 201B)

In exercise of the powers conferred by sections 6, 7 and 23 of the National Registry of Diseases Act, the Minister for Health hereby makes the following Regulations:

Citation and commencement

1. These Regulations may be cited as the National Registry of Diseases (Cancer Notification) Regulations 2009 and shall come into operation on 1st August 2009.

Definitions

2. In these Regulations, unless the context otherwise requires —

“cancer” includes in-situ neoplasms, neoplasms with borderline or uncertain malignant potential, as well as all tumours (malignant, borderline, in-situ and benign) of the brain and other parts of the central nervous system (including the pituitary gland, craniopharyngeal duct and pineal gland);

“patient” means a person to whom a notification referred to in regulation 3 relates.

Form, time and manner of notification for cancer

3. For the purposes of section 6(1) of the Act, a notification by the manager of a healthcare institution to the Registrar that a person has been diagnosed with or is undergoing treatment for cancer at the healthcare institution shall —

(a)

contain, in relation to that patient, the information specified in the First Schedule;

(b)

be made in any of the Forms set out in the Second Schedule or at the Registry’s Internet website at http://www.nrdo.gov.sg;

(c)

be sent to the Registrar —

(i)	by hand (including by courier);
(ii)	by registered mail; or
(iii)	by using such secure electronic notification system as may be approved by the Registrar; and

(d)

be made within the following time:

(i)	where the patient has been diagnosed with cancer through a confirmatory diagnostic test, not later than 3 months after the diagnosis of that cancer was first made; or
(ii)	where the patient is undergoing treatment for cancer in the healthcare institution, not later than 3 months after the treatment for that cancer commenced.

Collection of additional information under section 7 of Act

4. Upon receiving a notification referred to in regulation 3, the Registrar or an authorised Registry officer may, for the purposes of section 7(1) of the Act, require the manager of the healthcare institution who made the notification to provide all or any of the additional information specified in the Third Schedule concerning the patient.

FIRST SCHEDULE

Regulation 3(a)

Information of Patient to be Submitted With Notification

1. Identification number (including NRIC, passport number, Foreign Identification Number or hospital registration number).

2. Name.

3. Date of birth or age (if date of birth is unknown).

4. Name of notifying healthcare institution (including department).

5. Date the cancer was diagnosed.

6. Primary site of the cancer.

SECOND SCHEDULE

Regulation 3(b)

Forms of Notification

1. Cancer notification form set out at the Registry’s Internet website at http://www.nrdo.gov.sg.

2. Hospital inpatient discharge summaries.

3. Cancer case listings.

4. Nuclear medicine, radiotherapy, oncology, haematology or histopathology reports.

THIRD SCHEDULE

Regulation 4

Additional Information

1. Patient’s particulars:

(a)	gender;
(b)	ethnic group;
(c)	citizenship or resident status;
(d)	country of birth.

2. Details of notifying healthcare institution:

(a)	medical practitioner in charge of the case;
(b)	healthcare institution (including specific centre, department or clinic) responsible for subsequent treatment or follow-up;
(c)	person who made the notification.

3. Diagnosis information:

(a)	basis for diagnosis;
(b)	grade or differentiation;
(c)	histological diagnosis.

4. Current status of patient:

(a)	living or deceased;
(b)	where patient is deceased, the date, place and cause of death.

5. Clinical staging and treatment:

(a)	clinical stage of cancer;
(b)	tumour size;
(c)	treatment (including type and date of treatment).

6. Risk factors.

Made this 22nd day of July 2009.

YONG YING-I

Permanent Secretary,
Ministry of Health,
Singapore.

[MH(CF)78:81: AG/LEG/SL/201B/2007/1 Vol. 1]